Low rate of compliance with ergocalciferol therapy in vitamin-D-deficient patients with hip fracture

Medical Journal of Australia

Volumn 177, Issue 5, 2002, Pages 280-

  Noble, Jane M ^a   McGuiness, Marjory ^a   Glendenning, Paul ^a  

^a ROYAL PERTH HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ERGOCALCIFEROL; VITAMIN D;

CLINICAL TRIAL; DOCTOR PATIENT RELATION; DRUG COST; DRUG TOLERABILITY; DRUG WITHDRAWAL; HIP FRACTURE; HOSPITAL DISCHARGE; HUMAN; INTERPERSONAL COMMUNICATION; INTERVIEW; LETTER; MAJOR CLINICAL STUDY; MEDICAL AUDIT; OSTEOPOROSIS; PATIENT ATTITUDE; PATIENT COMPLIANCE; PRESCRIPTION; SIDE EFFECT; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY;

EID: 0037009380     PISSN: 0025729X     EISSN: None     Source Type: Journal    
DOI: 10.5694/j.1326-5377.2002.tb04775.x     Document Type: Letter

References (5)

1. Vitamin D3 and calcium to prevent hip fractures in the elderly women
2. Effect of calcium and vitamin D supplementation on bone density in men and women 65 years of age or older
3. Cost-effectiveness of preventing hip fractures in the elderly population using vitamin D and calcium
4. Vitamin D deficiency and multicultural Australia
5. Vitamin D deficiency: Time for action. Evidence supports routine supplementation for elderly people and others at risk